NASDAQ
Tekla Life Sciences Investors (HQL) has a revenue compound annual growth rate of 17.20% over 5 years and 51.88% over 10 years. Revenue CAGR shows the compound annual growth rate of a company's total sales, indicating the pace of top-line expansion.
No price data available for this timeframe.